- Conditions
- Gastric Intestinal Metaplasia, Gastric Precancer
- Interventions
- Pyrvinium, Placebo
- Drug
- Lead sponsor
- Katherine Garman
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
Source: ClinicalTrials.gov public record
Updated Feb 11, 2026 · Synced May 22, 2026, 3:48 AM EDT